AR
ARWR
Arrowhead Pharmaceuticals, Inc.
$82.85
1M -5.0%
3M +11.3%
YTD +22.2%
as of 2026-09-11
+Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Weak window historically
Next 30 days (to Oct 14): -2.8% median,
41% of the last 32 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 23
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.66%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.53 -0.3% · Seasonal tilt -0.2%
$108M/day volume
61% volatility
+187% 1-year
52-week range · 81% of the way up · -13% from the high
$27.94$95.49
Congressional trades in ARWR
Full tracker →
1 member · 0 buys / 1 sells
· $1K–$15K disclosed · latest filing Feb 24, 2023.
| SELL |
DG Daniel Goldman
· traded Jan 31, 2023 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.